+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Single Use Bioprocessing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product, Scale of Operation and Key Geographical Regions- Product Image
Single Use Bioprocessing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product, Scale of Operation and Key Geographical Regions- Product Image
New

Single Use Bioprocessing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product, Scale of Operation and Key Geographical Regions

  • PDF Icon

    Report

  • 220 Pages
  • March 2026
  • Region: Global
  • Roots Analysis
  • ID: 6230120
Description Jump to:
The single use bioprocessing market is estimated to grow from USD 5.8 billion in the current year to USD 15.5 billion by 2035, at a CAGR of 11.5% during the forecast period, till 2035.

Single Use Bioprocessing Market

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Product

  • Single Use Bioreactors
  • Single Use Mixers
  • Single Use Media Bags
  • Single Use Filters
  • Single Use Sampling Systems
  • Single Use Connectors
  • Others

Scale of Operation

  • Preclinical / Clinical
  • Commercial

Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

SINGLE USE BIOPROCESSING MARKET: GROWTH AND TRENDS

Biologics has become increasingly popular due to their therapeutic effectiveness, positive safety profiles, and capacity to address a range of disease indications that are otherwise difficult to manage. The effectiveness of these interventions encouraged the stakeholders to enhance the conventional biologics contract manufacturing technology. The need for enhanced productivity and flexibility, improved profitability, and quicker market delivery is further accelerating the shift from conventional stainless-steel equipment to single-use technologies, such as single-use mixers and single-use bioreactors. These disposable technologies have gained acceptance in a relatively brief time frame and have emerged as a crucial resource in the advancement of numerous biotechnological processes.

Additionally, the COVID-19 pandemic has driven the biopharmaceutical sector to adopt single-use technology. These single-use bioprocessing technologies reduce the footprint requirement and remove cleaning expenses during the development phase. Moreover, single-use bioprocessing technologies can tackle several issues linked to conventional bioprocessing systems and provide numerous extra advantages, including reduced water and energy use (by approximately 45%), lower capital investment (by 40%), shorter processing time for biologics (by 33%), diminished cross-contamination risk (by 8%), and greater potential for cost savings (by 30-40%).

Currently, numerous single-use bioprocessing firms are involved in developing and producing single-use upstream bioprocessing technologies and tools, including single-use bioreactors, single-use mixers, single-use filters, single-use media bags and containers, single-use sampling systems, and single-use connectors. Additionally, several of these bioprocessing firms are concentrating on adding extra functionalities, such as alert / notification systems, integrated process control sensors, digital process logs, remote supervision capabilities, touchscreen interfaces, and enhanced safety measures, to their proprietary products. The utilization of this single-use technology comes with various challenges, including the risks associated with extractables and leachable, disposal of single-use technology, sterilization / irradiation complications, and possible inconsistencies in the resins. However, due to ongoing sustainability research and other technical developments, we believe that the potential for technology providers in the single-use bioprocessing market is expected to see significant growth throughout the forecast period.

SINGLE USE BIOPROCESSING MARKET: KEY INSIGHTS

The report delves into the current state of the single use bioprocessing market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Over 500 single-use upstream bioprocessing equipment are currently commercially available / being developed; single-use bioreactors, single-use sensors and single-use mixers are steadily gaining traction.

  • In addition, companies have developed a variety of single-use media bags, single-use filters, single-use connectors and single-use sampling systems; these systems are inbuilt with various key features.
  • Majority of the single-use bioreactors are being used by the pharmaceutical / biopharmaceutical industry; of these, several have been deployed across different application areas.
  • Over 90% of the single-use mixers use liquid / liquid mixing system to obtain uniform composition of the components; a significant proportion of these mixers can be used across all scales of operations.
  • In pursuit of gaining a competitive edge, developers are focusing on introducing advanced features in their respective products.
  • More than 1,800 patents related to single-use bioprocessing technology have been filed by various industry and non-industry players; this is indicative of the heightened pace of research and innovation in this field.

  • Owing to the cost saving potential and other benefits of single-use technology, the adoption of this technology is expected to ration.
  • 57% of the pre-calibrated sensors are flow sensors; all the single-use sensors use gamma-irradiation sterilization technique.
  • The current market landscape features the presence of both well-established firms and new entrants; most of the companies are headquartered in developed regions.
  • Over time, stakeholders have established strong brand positions in order to cater to the increasing demand for single-use technology and to enhance their respective product portfolio.

  • The market is anticipated to grow at a CAGR of 11.5% in the coming decade; the opportunity is likely to be well distributed across different scales of operation, type of equipment and geographical regions.

SINGLE USE BIOPROCESSING MARKET: MARKET SEGMENTS

Preclinical and Clinical Scale is the Fastest Growing Segment of the Probiotics Market

In terms of scale of operation, the global market for single-use bioprocessing technology market is segmented into preclinical and clinical scale, and commercial scale. Currently, majority share (87%) of the market is captured by preclinical and clinical scale. Further, the clinical scale segment is likely to grow at a higher CAGR (10%) in the coming years.

Disposable Filter Cartridges are Likely to Grow at a Higher CAGR During the Forecast Period

Based on the type of product, the global market is segmented into single-use bioreactors, single-use mixing systems, single-use media-bags, single-use filters, single-use sampling system, single-use connectors, single-use membrane adsorbents, and single-use membrane adsorbents. amongst these types, the disposable filter cartridges are likely to witness highest growth during the forecast period, followed by media bags and single-use sampling system.

Disposable Filter Cartridges are Likely to Grow at a Higher CAGR During the Forecast Period

In terms of the type of product, the global market is segmented into single-use bioreactors, single-use mixing systems, single-use media-bags, single-use filters, single-use sampling system, single-use connectors, single-use membrane adsorbents, and single-use membrane adsorbents. amongst these types, the disposable filter cartridges are likely to witness highest growth during the forecast period, followed by media bags and single-use sampling system.

Asia-Pacific is Likely to Propel the Market Growth During the Forecast Period

In terms of the geographical regions, the global market is segmented into North America, Europe, Asia-Pacific, Latin America and Middel East and North Africa. Amongst these, Asia-Pacific is likely to capture most of the market share (35%), followed by North America (30%) and Europe (25%).

Example Players in the Single-use Bioprocessing Technology Market

  • Avantor
  • Cytiva
  • Eppendorf
  • Merck KGaA
  • Pall
  • Premas Biotech
  • REPROCELL
  • Saint-Gobain
  • Sartorius
  • Satake Multimix
  • Thermo Fisher Scientific

SINGLE USE BIOPROCESSING MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the single use bioprocessing market, focusing on key market segments, including [A] type of product, [B] scale of operation, and [C] geographical regions.
  • Market Landscape 1: A detailed assessment of overall market landscape of single-use bioreactors based on several relevant parameters, such as [A] scale of operation, [B] type of cell culture system, [C] type of cell culture, [D] type of molecule, [E] key features, [F] application and [G] end users.
  • Market Landscape 2: A detailed assessment of the overall market landscape of single-use mixers based on a number of relevant parameters, such as [A] scale of operation, [B] type of mixing system, [C] type of molecule, [D] key features [E] application area, [F] year of establishment, [G] company size, and [H] geographical presence.
  • Market Landscape 3: A detailed assessment of the overall market landscape of single-use sensors, based on several relevant parameters, such as [A] type of sensor, [B] type of bioprocessing, [C] measurement range, [D] operating temperature, [E] sterilization technique, [F] material used [G] application area, [H] year of establishment, [I] company size, and [J] geographical presence.
  • Company Competitiveness Analysis: A comprehensive competitive analysis of single use bioreactors, examining factors, such as [A] product applicability and [B] product strength.
  • Company Profiles: In-depth profiles of prominent players engaged in this domain, that are currently involved key bioprocessing companies providing single-use upstream bioprocessing technologies, which are headquartered in North America, Europe and Asia-Pacific, focusing on [A] year of establishment, [B] location of headquarters, [C] drug portfolio, [D] recent developments and [E] an informed future outlook.
  • Patent Analysis: An in-depth analysis of various patents that have been filed / granted for single-use upstream bioprocessing technology, based on relevant parameters, including [A] type of patents, [B] publication year, [C] application year, [D] issuing authorities involved, [E] type of organizations, [F] emerging focus area, [G] patent age, [H] CPC symbols, [I] leading patent assignees, [J] patent characteristics and [K] geography.
  • Brand Positioning Analysis: A detailed brand positioning analysis of the key industry players, highlighting the current perceptions regarding their proprietary products by taking into consideration several relevant aspects, such as [A] experience of the manufacturer, [B] number of products offered, [C] product diversity, and [D] number of patents published.
  • Cost and Time Saving Potential: An in-depth analysis of the cost and time saving potential of single-use upstream bioprocessing technology.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What is the current global capacity of developers?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs Covering All Analytical Modules
  • Up to 15% Complimentary Content Customization
  • In-Depth Report Walkthrough with the Research Team
  • Complimentary Report Update if the Report is 6+ Months Old

Table of Contents

1. PREFACE
1.1. Overview
1.2. Scope of the Report
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Single-use Upstream Bioprocessing Technology
3.3. Historical Evolution of Single-use Upstream Bioprocessing Technology
3.4. Types of Single-use Upstream Bioprocessing Technology
3.5. Applications of Single-use Upstream Bioprocessing Technology
3.6. Key Challenges Associated with Single-use Upstream Bioprocessing Technology
3.7. Future Perspective
4. MARKET LANDSCAPE: SINGLE-USE BIOREACTORS
4.1. Chapter Overview
4.2. Single-use Bioreactors: List of Products
4.2.1. Analysis by Type of Bioreactor
4.2.2. Analysis by Scale of Operation
4.2.3. Analysis by Type of Cell Culture System
4.2.4. Analysis by Type of Cell Culture
4.2.5. Analysis by Type of Molecule Processed
4.2.6. Analysis by Key Features
4.2.7. Analysis by Application Area
4.2.8. Analysis by End Users
4.3. Single-use Bioreactors: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.2. Analysis by Year of Establishment and Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Developers: Analysis by Number of Single-use Bioreactors
5. MARKET LANDSCAPE: SINGLE-USE MIXERS
5.1. Chapter Overview
5.2. Single-use Mixers: List of Products
5.2.1. Analysis by Scale of Operation
5.2.2. Analysis by Type of Mixing System
5.2.3. Analysis by Stage of Bioprocessing
5.2.4. Analysis by Type of Molecule Processed
5.2.5. Analysis by Key Features
5.2.6. Analysis by Application Area
5.3. Single-use Mixers: Developer Landscape
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Analysis by Year of Establishment and Location of Headquarters
5.3.5. Leading Developers: Analysis by Number of Single-use Mixers
6. MARKET LANDSCAPE: SINGLE-USE SENSORS
6.1. Chapter Overview
6.2. Single-use Sensors: List of Products
6.2.1 Analysis by Type of Sensor
6.2.2. Analysis by Stage of Bioprocessing
6.2.3. Analysis by Operating Temperature
6.2.4. Analysis by Sterilization Technique
6.2.5. Analysis by Sensor Calibration
6.2.6. Analysis by Type of Material Used
6.2.7. Analysis by Application Area
6.3. Single-use Sensors: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Leading Developers: Analysis by Number of Single-use Sensors
7. MARKET LANDSCAPE: OTHER SINGLE-USE UPSTREAM BIOPROCESSING TECHNOLOGIES
7.1. Chapter Overview
7.2. Single-use Media Bags and Containers
7.3. Single-use Filters
7.4. Single-use Sampling Systems
7.5. Single-use Connectors
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology
8.3. Assumptions / Key Parameters
8.4. Product Competitiveness Analysis: Single-use Bioreactors
8.4.1. Companies Headquartered in North America
8.4.2. Companies Headquartered in Europe
8.4.3. Companies Headquartered in Asia-Pacific and Rest of the World
8.5. Product Competitiveness Analysis: Single-use Mixers
8.5.1. Companies Headquartered in North America
8.5.2. Companies Headquartered in Europe
8.5.3. Companies Headquartered in Asia-Pacific and Rest of the World
8.6. Product Competitiveness Analysis: Single-use Sensors
8.6.1. Companies Headquartered in North America
8.6.2. Companies Headquartered in Europe
8.6.3. Companies Headquartered in Asia-Pacific and Rest of the World
9. SINGLE-USE UPSTREAM BIOPROCESSING TECHNOLOGY PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
9.1. Chapter Overview
9.2. Avantor
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service Portfolio
9.2.4. Product Portfolio
9.2.5. Recent Developments and Future Outlook
9.3. Cytiva
9.3.1. Company Overview
9.3.2. Financial Information
9.3.3. Service Portfolio
9.3.4. Product Portfolio
9.3.5. Recent Developments and Future Outlook
9.4. Merck KGaA
9.4.1. Company Overview
9.4.2. Financial Information
9.4.3. Service Portfolio
9.4.4. Product Portfolio
9.4.5. Recent Developments and Future Outlook
9.5. Pall
9.5.1. Company Overview
9.5.2. Financial Information
9.5.3. Service Portfolio
9.5.4. Product Portfolio
9.5.5. Recent Developments and Future Outlook
9.6. Thermo Fisher Scientific
9.6.1. Company Overview
9.6.2. Financial Information
9.6.3. Service Portfolio
9.6.4. Product Portfolio
9.6.5. Recent Developments and Future Outlook
10. SINGLE-USE UPSTREAM BIOPROCESSING TECHNOLOGY PROVIDERS IN EUROPE: COMPANY PROFILES
10.1. Chapter Overview
10.2. Eppendorf
10.2.1. Company Overview
10.2.2. Financial Information
10.2.3. Service Portfolio
10.2.4. Product Portfolio
10.2.5. Recent Developments and Future Outlook
10.3. Saint-Gobain
10.3.1. Company Overview
10.3.2. Financial Information
10.3.3. Service Portfolio
10.3.4. Product Portfolio
10.3.5. Recent Developments and Future Outlook
10.4. Sartorius
10.4.1. Company Overview
10.4.2. Financial Information
10.4.3. Service Portfolio
10.4.4. Product Portfolio
10.4.5. Recent Developments and Future Outlook
11. SINGLE-USE UPSTREAM BIOPROCESSING TECHNOLOGY PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
11.1. Chapter Overview
11.2. Satake Multimix
11.2.1. Company Overview
11.2.2. Financial Information
11.2.3. Service Portfolio
11.2.4. Product Portfolio
11.2.5. Recent Developments and Future Outlook
11.3. REPROCELL
11.3.1. Company Overview
11.3.2. Financial Information
11.3.3. Service Portfolio
11.3.4. Product Portfolio
11.3.5. Recent Developments and Future Outlook
11.4. Premas Biotech
11.4.1. Company Overview
11.4.2. Financial Information
11.4.3. Service Portfolio
11.4.4. Product Portfolio
11.4.5. Recent Developments and Future Outlook
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Single-use Upstream Bioprocessing Technology: Patent Analysis
12.3.1. Analysis by Publication Year
12.3.2. Analysis by Application Year
12.3.3. Analysis by Patent Office
12.3.4. Analysis by Geographical Location
12.3.5. Analysis by CPC Symbols
12.3.6. Emerging Focus Area
12.3.7. Analysis by Type of Organization
12.3.8. Leading Players: Analysis by Number of Patents
12.4. Patent Benchmarking Analysis
12.4.1. Analysis by Patent Characteristics
12.5. Analysis by Patent Valuation
13. BRAND POSITIONING MATRIX
13.1. Chapter Overview
13.2 Methodology
13.3. Key Parameters
13.4. Brand Positioning Matrix of Single-use Bioreactor Developers
13.4.1. Brand Positioning Matrix: Pall Corporation
13.4.2. Brand Positioning Matrix: Eppendorf
13.4.3. Brand Positioning Matrix: Solaris Biotech
13.4.4. Brand Positioning Matrix: Sartorius Stedim Biotech
13.4.5. Brand Positioning Matrix: Applikon Biotechnology
13.4.6. Brand Positioning Matrix: CerCell
13.4.7. Brand Positioning Matrix: Synthecon
13.5. Brand Positioning Matrix of Single-use Mixer Developers
13.5.1. Brand Positioning Matrix: Thermo Fisher Scientific
13.5.2. Brand Positioning Matrix: Merck Millipore
13.5.3. Brand Positioning Matrix: Cytiva Lifesciences
13.5.4. Brand Positioning Matrix: Pall Corporation
13.6. Brand Positioning Matrix of Single-use Sensors Developers
13.6.1. Brand Positioning Matrix: Masterflex
13.6.2. Brand Positioning Matrix: Levitronix
13.6.3. Brand Positioning Matrix: Malema Engineering
13.6.4. Brand Positioning Matrix: Parken Hannifin
13.6.5. Brand Positioning Matrix: Pendo TECH
14. CASE STUDY: COST AND TIME SAVING POTENTIAL OF SINGLE-USE UPSTREAM BIOPROCESSING TECHNOLOGY
14.1. Chapter Overview
14.2. Overall Cost Saving Potential of Single-Use Upstream Bioprocessing Technology, Till 2035
14.2.1. Scenario 1
14.2.1.1. Key Assumptions and Methodology
14.2.1.2. Cost Saving Potential with Acquisition of Single-Use Upstream Technology, Till 2035
14.2.2. Scenario 2
14.2.2.1. Key Assumptions and Methodology
14.2.2.2. Cost Saving Potential with Implementation of Single-Use Upstream Bioprocessing Technology, Till 2035
14.3. Overall Time Saving Potential of Single-Use Upstream Bioprocessing Technology, Till 2035
14.4. Concluding Remarks
15. DEMAND AND SUPPLY ANALYSIS
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Global Demand for Biologics, Till 2035
15.3.1. Demand Vs Supply Scenario 1
15.3.2. Demand Vs Supply Scenario 2
15.3.3. Demand Vs Supply Scenario 3
15.3.4. Demand Vs Supply Scenario 4
15.4. Concluding Remarks
16. MARKET FORECAST AND OPPORTUNITY ANALYSIS
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Single-use Upstream Bioprocessing Technology Market, Till 2035
16.3.1. Global Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Scale of Operation
16.3.1.1. Global Single-use Upstream Bioprocessing Technology Market for Preclinical / Clinical Operations, Till 2035
16.3.1.2. Global Single-use Upstream Bioprocessing Technology Market for Commercial Operations, Till 2035
16.3.2. Global Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Type of Equipment
16.3.2.1. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Bioreactors, Till 2035
16.3.2.2. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Mixers, Till 2035
16.3.2.3. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Media Bags, Till 2035
16.3.2.4. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Filters, Till 2035
16.3.2.5. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Sampling Systems, Till 2035
16.3.2.6. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Connectors, Till 2035
16.3.2.7. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Membrane Adsorbers, Till 2035
16.3.2.8. Global Single-use Upstream Bioprocessing Technology Market for Other Single-Use Technologies, Till 2035
16.3.3. Global Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Geographical Region
16.3.3.1. Global Single-use Upstream Bioprocessing Technology Market in North America, Till 2035
16.3.2.1.1. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Bioreactors in North America, Till 2035
16.3.2.1.2. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Mixers in North America, Till 2035
16.3.2.1.3. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Media Bags in North America, Till 2035
16.3.2.1.4. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Filters in North America, Till 2035
16.3.2.1.5. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Sampling Systems in North America, Till 2035
16.3.2.1.6. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Connectors in North America, Till 2035
16.3.2.1.7. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Membrane Adsorbers in North America, Till 2035
16.3.2.1.8. Global Single-use Upstream Bioprocessing Technology Market for Other Single-Use Technologies in North America, Till 2035
16.3.3.2. Global Single-use Upstream Bioprocessing Technology Market in Europe, Till 2035
16.3.2.2.1. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Bioreactors in Europe, Till 2035
16.3.2.2.2. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Mixers in Europe, Till 2035
16.3.2.2.3. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Media Bags in Europe, Till 2035
16.3.2.2.4. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Filters in Europe, Till 2035
16.3.2.2.5. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Sampling Systems in Europe, Till 2035
16.3.2.2.6. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Connectors in Europe, Till 2035
16.3.2.2.7. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Membrane Adsorbers in Europe, Till 2035
16.3.2.2.8. Global Single-use Upstream Bioprocessing Technology Market for Other Single-Use Technologies in Europe, Till 2035
16.3.3.3. Global Single-use Upstream Bioprocessing Technology Market in Asia-Pacific, Till 2035
16.3.2.3.1. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Bioreactors in Asia-Pacific, Till 2035
16.3.2.3.2. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Mixers in Asia-Pacific, Till 2035
16.3.2.3.3. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Media Bags in Asia-Pacific, Till 2035
16.3.2.3.4. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Filters in Asia-Pacific, Till 2035
16.3.2.3.5. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Sampling Systems in Asia-Pacific, Till 2035
16.3.2.3.6. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Connectors in Asia-Pacific, Till 2035
16.3.2.3.7. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Membrane Adsorbers in Asia-Pacific, Till 2035
16.3.2.3.8. Global Single-use Upstream Bioprocessing Technology Market for Other Single-Use Technologies in Asia-Pacific, Till 2035
16.3.3.4. Global Single-use Upstream Bioprocessing Technology Market in Latin America, Till 2035
16.3.2.4.1. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Bioreactors in Latin America, Till 2035
16.3.2.4.2. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Mixers in Latin America, Till 2035
16.3.2.4.3. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Media Bags in Latin America, Till 2035
16.3.2.4.4. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Filters in Latin America, Till 2035
16.3.2.4.5. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Sampling Systems in Latin America, Till 2035
16.3.2.4.6. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Connectors in Latin America, Till 2035
16.3.2.4.7. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Membrane Adsorbers in Latin America, Till 2035
16.3.2.4.8. Global Single-use Upstream Bioprocessing Technology Market for Other Single-Use Technologies in Latin America, Till 2035
16.3.3.5. Global Single-Use Upstream Bioprocessing Technology Market in Middle East and North Africa, Till 2035
16.3.2.5.1. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Bioreactors in Middle East and North Africa, Till 2035
16.3.2.5.2. Global Single-use Upstream Bioprocessing Technology Market for Single- Use Mixers in Middle East and North Africa, Till 2035
16.3.2.5.3. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Media Bags in Middle East and North Africa, Till 2035
16.3.2.5.4. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Filters in Middle East and North Africa, Till 2035
16.3.2.5.5. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Sampling Systems in Middle East and North Africa, Till 2035
16.3.2.5.6. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Connectors in Middle East and North Africa, Till 2035
16.3.2.5.7. Global Single-use Upstream Bioprocessing Technology Market for Single-Use Membrane Adsorbers in Middle East and North Africa, Till 2035
16.3.2.5.8. Global Single-use Upstream Bioprocessing Technology Market for Other Single-Use Technologies in Middle East and North Africa, Till 2035
17. CONCLUSION
17.1. Chapter Overview
18. EXECUTIVE INSIGHTS19. APPENDIX 1: TABULATED DATA20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 3.1 Types of Biologics
Figure 3.2 Stages of the Drug Development Process
Figure 3.3 Commonly Offered Services by CROs
Figure 3.4 Advantages of Outsourcing Operations to CROs
Figure 3.5 Risks Associated with Outsourcing Operations to CROs
Figure 4.1 Guiding Models for Outsourcing
Figure 4.2 Key Characteristics of Transactional Outsourcing Model
Figure 4.3 Key Characteristics of Performance / Outcome based Business Model
Figure 4.4 Steps to Consider before Outsourcing
Figure 4.5 Key Considerations while Selecting a CRO Partner
Figure 4.6 Role of CROs in the Drug Development Process
Figure 5.1 Biopharmaceutical CROs: Distribution by Year of Establishment, Company Size and Location of Headquarters
Figure 5.2 Biopharmaceutical CROs: Distribution by Scale of Operation
Figure 5.3 Biopharmaceutical Preclinical CROs: Distribution by Year of Establishment
Figure 5.4 Biopharmaceutical Preclinical CROs: Distribution by Company Size
Figure 5.5 Biopharmaceutical Preclinical CROs Distribution by Location of Headquarters
Figure 5.6 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics
Figure 5.7 Biopharmaceutical Preclinical CROs: Distribution by Types of Services Offered
Figure 5.8 Biopharmaceutical Preclinical CROs: Distribution by Number of Services Offered
Figure 5.9 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics and Types of Services Offered
Figure 5.10 Biopharmaceutical Clinical CROs: Distribution by Year of Establishment
Figure 5.11 Biopharmaceutical Clinical CROs: Distribution by Company Size
Figure 5.12 Biopharmaceutical Clinical CROs: Distribution by Location of Headquarters
Figure 5.13 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics
Figure 5.14 Biopharmaceutical Clinical CROs: Distribution by Types of Services Offered
Figure 5.15 Biopharmaceutical Clinical CROs: Distribution by Number of Services Offered
Figure 5.16 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics and Types of Services Offered
Figure 6.1 Biocon: Annual Services Revenues, Since 2016 (INR Billion)
Figure 6.2 Biocon: Service Portfolio
Figure 6.3 Covance: Annual Services Revenues, Since 2016 (USD Billion)
Figure 6.4 Covance: Service Portfolio
Figure 6.5 ICON: Annual Revenues, Since 2016 (USD Billion)
Figure 6.6 ICON: Service Portfolio
Figure 6.7 Medpace: Annual Services Revenues, Since 2016 (USD Billion)
Figure 6.8 Medpace: Service Portfolio
Figure 6.9 Medpace: Regulatory Affair Capabilities
Figure 6.10 Pharmaron: Service Portfolio
Figure 6.11 PPD: Annual Services Revenues, Since 2016 (USD Billion)
Figure 6.12 PPD: Service Portfolio
Figure 6.13 PRA Health Sciences: Annual Revenues, Since 2016 (USD Billion)
Figure 6.14 PRA Health Sciences: Service Portfolio
Figure 6.15 Syneos Health: Annual Services Revenues, Since 2016 (USD Billion)
Figure 6.16 Syneos Health: Service Portfolio
Figure 6.17 Vimta Labs: Annual Service Revenues, Since 2016 (INR Billion)
Figure 6.18 Vimta Labs: Service Portfolio
Figure 6.19 WuXi App Tec: Annual Services Revenues, Since 2016 (USD Billion)
Figure 6.20 WuXi App Tec: Service Portfolio
Figure 7.1 Benchmark Analysis: Distribution by Company Size and Location of Headquarters
Figure 7.2 Benchmark Analysis: Peer Group I
Figure 7.3 Benchmark Analysis: Peer Group II
Figure 7.4 Benchmark Analysis: Peer Group III
Figure 7.5 Benchmark Analysis: Peer Group IV
Figure 7.6 Benchmark Analysis: Peer Group V
Figure 7.7 Benchmark Analysis: Peer Group VI
Figure 7.8 Benchmark Analysis: Peer Group VII
Figure 7.9 Benchmark Analysis: Peer Group VIII
Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership Model
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership Model
Figure 8.4 Most Active Players: Distribution by Number of Partnerships
Figure 8.5 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 8.6 Partnerships and Collaborations: Distribution by Geography
Figure 8.7 Partnerships and Collaborations: Country-Wise Distribution
Figure 8.8 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.1 Mergers and Acquisitions: Distribution by Year of Merger / Acquisition (Since 2016)
Figure 9.2 Mergers and Acquisitions: Distribution by Type of Merger / Acquisition
Figure 9.3 Mergers and Acquisitions: Distribution by Year and Type of Merger / Acquisition
Figure 9.4 Mergers and Acquisitions: Continent-wise Distribution
Figure 9.5 Mergers and Acquisitions: Region-wise Distribution
Figure 9.6 Mergers and Acquisitions: Country-wise Distribution
Figure 9.7 Mergers and Acquisitions: Ownership Change Matrix
Figure 9.8 Mergers and Acquisitions: Key Value Drivers
Figure 9.9 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 9.10 Mergers and Acquisitions: Deal Multiples Based on Revenue
Figure 9.11 Mergers and Acquisitions: Deal Multiples Based on Year of Experience
Figure 10.1. AC Matrix: Pictorial Representation
Figure 10.2. AC Matrix: Positioning of Different Biologics in North America
Figure 10.3. AC Matrix: Positioning of Different Biologics in Europe
Figure 10.4. AC Matrix: Positioning of Different Biologics in Asia Pacific
Figure 11.1 Biopharmaceutical CROs: Market Forecast Methodology
Figure 11.2 Global Biopharmaceutical CROs Market, Till 2035
Figure 11.3 Global Biopharmaceutical CROs Market: Distribution by Types of Biologics
Figure 11.4 Global Biopharmaceutical CROs Market: Distribution by Therapeutic Area
Figure 11.5 Global Biopharmaceutical CROs Market: Distribution by Scale of Operation
Figure 11.6 Global Biopharmaceutical CROs Market: Distribution by Geography
Figure 11.7 Biopharmaceutical CROs Market in North America, Till 2035 (USD Million)
Figure 11.8 Biopharmaceutical CROs Market for Oncological Disorders in North America, Till 2035 (USD Million)
Figure 11.9 Biopharmaceutical CROs Market for Cardiovascular Disorders in North America, Till 2035 (USD Million)
Figure 11.10 Biopharmaceutical CROs Market for Inflammatory Disorders in North America, Till 2035 (USD Million)
Figure 11.11 Biopharmaceutical CROs Market for Neurological Disorders in North America, Till 2035 (USD Million)
Figure 11.12 Biopharmaceutical CROs Market for Other Therapeutic Areas in North America, Till 2035 (USD Million)
Figure 11.13 Biopharmaceutical CROs Market for Preclinical Operations in North America, Till 2035 (USD Million)
Figure 11.14 Biopharmaceutical CROs Market for Clinical Operations in North America, Till 2035 (USD Million
Figure 11.15 Biopharmaceutical CROs Market in Europe, Till 2035 (USD Million)
Figure 11.16 Biopharmaceutical CROs Market for Oncological Disorders in Europe, Till 2035 (USD Million)
Figure 11.17 Biopharmaceutical CROs Market for Cardiovascular Disorders in Europe, Till 2035 (USD Million)
Figure 11.18 Biopharmaceutical CROs Market for Inflammatory Disorders in Europe, Till 2035 (USD Million)
Figure 11.19 Biopharmaceutical CROs Market for Neurological Disorders in Europe, Till 2035 (USD Million)
Figure 11.20 Biopharmaceutical CROs Market for Other Therapeutic Areas in Europe, Till 2035 (USD Million)
Figure 11.21 Biopharmaceutical CROs Market for Preclinical Operations in Europe, Till 2035 (USD Million)
Figure 11.22 Biopharmaceutical CROs Market for Clinical Operations in Europe, Till 2035 (USD Million)
Figure 11.23 Biopharmaceutical CROs Market in Asia-Pacific, Till 2035 (USD Million)
Figure 11.24 Biopharmaceutical CROs Market for Oncological Disorders in Asia-Pacific, Till 2035 (USD Million)
Figure 11.25 Biopharmaceutical CROs Market for Cardiovascular Disorders in Asia-Pacific, Till 2035 (USD Million)
Figure 11.26 Biopharmaceutical CROs Market for Inflammatory Disorders in Asia-Pacific, Till 2035 (USD Million)
Figure 11.27 Biopharmaceutical CROs Market for Neurological Disorders in Asia-Pacific, Till 2035 (USD Million)
Figure 11.28 Biopharmaceutical CROs Market for Other Therapeutic Areas in Asia-Pacific, Till 2035 (USD Million)
Figure 11.29 Biopharmaceutical CROs Market for Preclinical Operations in Asia-Pacific, Till 2035 (USD Million)
Figure 11.30 Biopharmaceutical CROs Market for Clinical Operations in Asia-Pacific, Till 2035 (USD Million)
Figure 11.31 Biopharmaceutical CROs Market in Latin America, Till 2035 (USD Million)
Figure 11.32 Biopharmaceutical CROs Market in Middle East North Africa, Till 2035 (USD Million)
Figure 11.33 Biopharmaceutical CROs Market: Conservative, Base and Optimistic Scenarios (USD Million)
Figure 12.1 Biopharmaceutical CROs SWOT Analysis: Overview
Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 13.1 Concluding Remarks: Current Market Landscape for Preclinical Biopharmaceutical CROs
Figure 13.2 Concluding Remarks: Current Market Landscape for Clinical Biopharmaceutical CROs
Figure 13.3 Concluding Remarks: Recent Partnerships
Figure 13.4 Concluding Remarks: Mergers and Acquisitions
Figure 13.5 Concluding Remarks: Clinical Trial Analysis
Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis
LIST OF TABLES
Table 4.1 Attributes of Transactional Outsourcing Based Business Model
Table 4.2 Comparison of Key Factors Considered by Biologic Developers for Selecting a CRO Partner: Harvey Ball Analysis
Table 5.1 Biopharmaceutical CROs: Information on Year of Establishment, Location of Headquarters, Company Size and Types of Biologics
Table 5.2 Biopharmaceutical Preclinical CROs: Information on Types of Services Offered
Table 5.3 Biopharmaceutical Clinical CROs: Information on Types of Services Offered
Table 6.1 Biocon: Company Overview
Table 6.2 Biocon: Future Outlook
Table 6.3 Covance: Company Overview
Table 6.4 Covance: Future Outlook
Table 6.5 ICON: Company Overview
Table 6.6 ICON: Future Outlook
Table 6.7 Medpace: Company Overview
Table 6.8 Medpace: Future Outlook
Table 6.9 Pharmaron: Company Overview
Table 6.10 Pharmaron: Future Outlook
Table 6.11 PPD: Company Overview
Table 6.12 PPD: Future Outlook
Table 6.13 PRA Health Sciences: Company Overview
Table 6.14 PRA Health Sciences: Future Outlook
Table 6.15 Syneos Health: Company Overview
Table 6.16 Syneos Health: Future Outlook
Table 6.17 VIMTA Labs: Company Overview
Table 6.18 WuXi App-Tec: Company Overview
Table 6.19 WuXi App Tec: Future Outlook
Table 7.1 Benchmark Analysis: Peer Groups
Table 8.1 Partnerships and Collaborations: List of Agreements, Since 2016
Table 9.1 Mergers and Acquisitions: List of Mergers / Acquisitions, Since 2016
Table 9.2 Mergers and Acquisitions: Information on Key Value Drivers, Since 2016
Table 9.3 Mergers and Acquisitions: Deal Multiples, Since 2016
Table 15.1 Biopharmaceutical CROs: Distribution by Year of Establishment, Company Size and Location of Headquarters
Table 15.2 Biopharmaceutical CROs: Distribution by Scale of Operation
Table 15.3 Biopharmaceutical Preclinical CROs: Distribution by Year of Establishment
Table 15.4 Biopharmaceutical Preclinical CROs: Distribution by Company Size
Table 15.5 Biopharmaceutical Preclinical CROs Distribution by Location of Headquarters
Table 15.6 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics
Table 15.8 Biopharmaceutical Preclinical CROs: Distribution by Types of Services Offered
Table 15.9 Biopharmaceutical Preclinical CROs: Distribution by Number of Services Offered
Table 15.10 Biopharmaceutical Preclinical CROs: Distribution by Types of Biologics and Types Services Offered
Table 15.11 Biopharmaceutical Clinical CROs: Distribution by Year of Establishment
Table 15.12 Biopharmaceutical Clinical CROs: Distribution by Company Size
Table 15.13 Biopharmaceutical Clinical CROs: Distribution by Location of Headquarters
Table 15.14 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics
Table 15.15 Biopharmaceutical Clinical CROs: Distribution by Types of Services Offered
Table 15.16 Biopharmaceutical Clinical CROs: Distribution by Number of Services Offered
Table 15.17 Biopharmaceutical Clinical CROs: Distribution by Types of Biologics and Types of Services Offered
Table 15.18 Biocon: Annual Service Revenues, Since 2016 (INR Billion)
Table 15.19 Covance: Annual Service Revenues, Since 2016 (USD Billion)
Table 15.20 ICON: Annual Revenues, Since 2016 (USD Billion)
Table 15.21 Medpace: Annual Service Revenues, Since 2016 (USD Billion)
Table 15.22 PPD: Annual Service Revenues, Since 2016 (USD Billion)
Table 15.23 PRA Health Sciences: Annual Revenues, Since 2016 (USD Billion)
Table 15.24 Syneos: Annual Service Revenues, Since 2016 (USD Billion)
Table 15.25 Vimta Labs: Annual Service Revenues, Since 2016 (INR Billion)
Table 15.26 WuXi AppTec: Annual Service Revenues, Since 2016 (USD Billion)
Table 15.27 Partnerships and Collaborations: Distribution by Year of Partnership
Table 15.28 Partnerships and Collaborations: Distribution by Type of Partnership Model
Table 15.29 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership Model
Table 15.30 Most Active Players: Distribution by Number of Partnerships
Table 15.31 Partnerships and Collaborations: Distribution by Scale of Operation
Table 15.32 Partnerships and Collaborations: Distribution by Geography
Table 15.33 Partnerships and Collaborations: Country-Wise Distribution
Table 15.34 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.35 Mergers and Acquisitions: Distribution by Year of Merger / Acquisition (Since 2016)
Table 15.36 Mergers and Acquisitions: Distribution by Type of Merger / Acquisition
Table 15.37 Mergers and Acquisitions: Distribution by Year and Type of Agreement
Table 15.38 Mergers and Acquisitions: Continent-wise Distribution
Table 15.39 Mergers and Acquisitions: Continent-wise Distribution
Table 15.40 Mergers and Acquisitions: Country-wise Distribution
Table 15.41 Mergers and Acquisitions: Ownership Change Matrix
Table 15.42 Mergers and Acquisitions: Key Value Drivers
Table 15.43 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Table 15.44 Mergers and Acquisitions: Deal Multiples Based on Revenue
Table 15.45 Mergers and Acquisitions: Deal Multiples Based on Year of Experience
Table 15.46 Global Biopharmaceutical CROs Market: Distribution by Types of Biologics
Table 15.47 Global Biopharmaceutical CROs Market: Distribution by Therapeutic Area
Table 15.48 Global Biopharmaceutical CROs Market: Distribution by Scale of Operation
Table 15.49 Global Biopharmaceutical CROs Market: Distribution by Geography
Table 15.50 Biopharmaceutical CROs Market in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.51 Biopharmaceutical CROs Market for Oncological Disorders in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.52 Biopharmaceutical CROs Market for Cardiovascular Disorders in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.53 Biopharmaceutical CROs Market for Inflammatory Disorders in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.54 Biopharmaceutical CROs Market for Neurological Disorders in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.55 Biopharmaceutical CROs Market for Other Therapeutic Areas in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.56 Biopharmaceutical CROs Market for Preclinical Operations in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.57 Biopharmaceutical CROs Market for Clinical Operations in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.58 Biopharmaceutical CROs Market in Europe, Till 2035 (USD Million)
Table 15.59 Biopharmaceutical CROs Market for Oncological Disorders in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.60 Biopharmaceutical CROs Market for Cardiovascular Disorders in Europe, Till 2035 (USD Million)
Table 15.61 Biopharmaceutical CROs Market for Inflammatory Disorders in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.62 Biopharmaceutical CROs Market for Neurological Disorders in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.63 Biopharmaceutical CROs Market for Other Therapeutic Areas in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.64 Biopharmaceutical CROs Market for Preclinical Operations in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.65 Biopharmaceutical CROs Market for Clinical Operations in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.66 Biopharmaceutical CROs Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.67 Biopharmaceutical CROs Market for Oncological Disorders in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.68 Biopharmaceutical CROs Market for Cardiovascular Disorders in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.69 Biopharmaceutical CROs Market for Inflammatory Disorders in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.70 Biopharmaceutical CROs Market for Neurological Disorders in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.71 Biopharmaceutical CROs Market for Other Therapeutic Areas in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.72 Biopharmaceutical CROs Market for Preclinical Operations in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.73 Biopharmaceutical CROs Market for Clinical Operations in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.74 Biopharmaceutical CROs Market for Preclinical Operations in Latin America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.75 Biopharmaceutical CROs Market for Preclinical Operations in Middle East North Africa, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 15.76 Biopharmaceutical CROs Market: Conservative, Base and Optimistic Scenarios (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M
  • ABEC
  • Acceleron Pharma
  • Applied BioSensors
  • Applikon Biotechnology
  • Avantor
  • Bionet
  • Bioprocess Engineering Services
  • Biosan
  • Celartia
  • Cell Culture Company
  • CellBios Healthcare & Lifesciences Pvt. Ltd
  • Cellexus
  • Celltainer Biotech
  • Cercell
  • CESCO Bioengineering
  • Corning
  • Cytiva
  • Distek
  • DrM Life Science
  • Emerson
  • Entegris
  • Eppendorf
  • Equflow
  • ErtelAlsop
  • ESCO ASTER
  • Finesse Solutions
  • FlexBiosys
  • High Purity New England
  • Integra Biosciences
  • LFB Biomanufacturing
  • Malema Engineering Corporation
  • Masterflex
  • Meissner
  • Meissner Filtration Product
  • Merck Millipore
  • METTLER TOLEDO
  • MicroDigital
  • OmniBRx biotechnologies
  • Optek-Danulat
  • Pall Corporation
  • Parker Hannifin
  • PBS Biotech
  • PerfuseCell
  • Polestar Technologies
  • PPD
  • Premas Biotech
  • PreSens
  • ProlifeCell
  • RealBio Technology
  • Rentschler Biopharma
  • REPROCELL
  • RIM Bio
  • Saint-Gobain
  • Sartorius Stedim Biotech
  • SATAKE MultiMix
  • Scinus Cell Expansion System
  • Sensirion
  • Sentinel Process Systems
  • Solaris Biotech
  • Solida Biotech
  • Strain Measurement Devices
  • Synthecon
  • Thermo Fisher Scientific
  • Univercells
  • Venair Group

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Single Use Bioprocessing Market Report 2026 - Product Image

Single Use Bioprocessing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Portable Bioprocessing Bioreactors Market Report 2026 - Product Image

Portable Bioprocessing Bioreactors Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Single-Use Bioprocessing - Global Strategic Business Report - Product Image

Single-Use Bioprocessing - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Upstream Bioprocessing Market Report 2026 - Product Image

Upstream Bioprocessing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key Geographical Regions - Product Image

Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key Geographical Regions

  • Report
  • 224 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.